Episode 344: Big Data Leads to Big Breakthroughs in MS with Professor Sergio Baranzini episode artwork

EPISODE · Apr 1, 2024 · 33 MIN

Episode 344: Big Data Leads to Big Breakthroughs in MS with Professor Sergio Baranzini

from RealTalk MS · host Jon Strum and Professor Sergio Baranzini

If you're a regular listener, you've probably heard me say that the pace of scientific discovery is moving faster than ever before. Or you may have heard the National MS Society remind us that we've seen as many advances in MS research in the past 5 years as we have in the previous 70 years. Have you ever wondered why? A major driver of this acceleration of discovery is the technology that allows scientists to analyze massive amounts of information looking for relationships or identifying characteristics that, without this technology, would be impossible to see.  This category of tech is commonly referred to as big data. And we're closer than we've ever been to understanding the biological complexities of multiple sclerosis because we've learned to harness the computing power that allows scientists to discover those very small needles among those very large haystacks. My guest in this episode is Professor Sergio Baranzini. Professor Baranzini is this year's recipient of the Barancik Prize for Innovation in MS Research and he's someone who has successfully leveraged big data to drive big, game-changing discoveries in multiple sclerosis. We'll also share some good news about MS research funding from the federal government.  We'll review newly published results from a study that has identified 3 subtypes of MS, each with a different disease trajectory. We'll share evidence from a study that focused on whether people over the age of 50 with nonactive MS should discontinue their disease-modifying therapy. And we'll tell you about the Canadian regulatory approval of a software-based medical device that can monitor MS disease activity by tracking eye movement -- all from an iPad that people with MS can use at home. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: We're saluting Professor Sergio Baranzini, this year's winner of the Barancik Prize  :22 Congress provides $20 million in FY2024 funding for the MS Research Program  1:57 A German research team has identified 3 subtypes of MS based on their unique immune cell signature found in a blood sample  4:10 A French research team focused their study on whether people over the age of 50 with nonactive MS should discontinue their DMT. Here's what they discovered  8:58 Health Canada has approved ETNA-MS. A software-based medical device that can monitor MS disease activity by tracking eye movement  12:48 Professor Sergio Baranzini discusses how big data has fundamentally changed scientific research, and how he's using it to find cures for MS  16:44 Share this episode  32:03 Have you downloaded the free RealTalk MS app?  32:24 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/344 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com REGISTER for the MS Activist Rally https://events.zoom.us/ev/Ame2jWSuHmriG94cyQmlWHr45mgnzxkDv8oMZRGsrS3ZxiSj5rro~Anqb3dHg3ewiz4KNHn2Ena4bgli_WXlza_zcygZN3GinnleB6rO15OCzGQ STUDY: Multiple Sclerosis Endophenotypes Identified by High-Dimensional Blood Signatures are Associated with Distinct Disease Trajectories https://science.org/doi/10.1126/scitranslmed.ade8560 STUDY: High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older with Nonactive MS https://jamanetwork.com/journals/jamaneurology/article-abstract/2816799 Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 344 Guest: Professor Sergio Baranzini Privacy Policy  

NOW PLAYING

Episode 344: Big Data Leads to Big Breakthroughs in MS with Professor Sergio Baranzini

0:00 33:42

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of RealTalk MS?

This episode is 33 minutes long.

When was this RealTalk MS episode published?

This episode was published on April 1, 2024.

What is this episode about?

If you're a regular listener, you've probably heard me say that the pace of scientific discovery is moving faster than ever before. Or you may have heard the National MS Society remind us that we've seen as many advances in MS research in the past 5...

Can I download this RealTalk MS episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!